Discover the IDEXX cancer portfolio.
Let’s make cancer history.
With a full suite of diagnostic tools for every phase of the patient journey, IDEXX is a trusted leader in veterinary oncology. Detect lymphoma earlier with IDEXX Cancer Dx testing.1 And tap into world-class pathology, hematology, and radiology services, when and where you need them.
How do you return unconditional love? With science.
Our love for pets motivates everything we do. By staying on the cutting edge of oncology, we hope to inspire new treatments, new therapies, new data, and a better future for all pets.
dogs in the U.S. will be diagnosed with cancer in their lifetime.²
of pet owners globally consider their pet a part of their family.³
Our vision for cancer begins with seeing it early.
Canine cancer is the leading cause of death in adult dogs. But what if we could change that? Whether you’re screening for early cancer or managing treatment, we can help you provide the best possible care.
IDEXX Cancer Dx testing
Support a clinical diagnosis of lymphoma earlier in at-risk dogs.*
Pathology services
Comprehensive support to help you make well- informed, timely decisions for your pathology cases.
Radiology and telemedicine consultants
Dependable answers to your routine and challenging diagnostic questions, when you need them.
Digital cytology
Personalized guidance from veterinary clinical pathologists.
The cancer diagnostics test and service menu gives you the answers you need, when you need them.
Cancer screening
- IDEXX Cancer Dx testing
Cancer identification
- IDEXX Cancer Dx testing
- Priority Cytology
- Priority Biopsy
- Bone Marrow Cytology and Biopsy with Microscopic Description
Cancer characterization
- Mast Cell Tumor Prognostic Panel
- Immunocytochemical Staining, as recommended by pathology
- Immunohistochemistry, as recommended by pathology
- Lymphoma PCR, includes the PARR assay for clonality
Genomic test for treatment selection suggestions
- FidoCure DNA Sequencing Panel Add-on to Biopsy
Chemotherapy patient monitoring
- Cancer Baseline Profile with Urinalysis
- Cancer Baseline Profile and SediVue Dx Urinalysis†
- Chemotherapy Recheck Profile
- Chemotherapy Recheck Profile with Urinalysis
You support your patients, our medical consultants support you.
Get comprehensive support from IDEXX Medical Consulting Services around treatment and prognosis for every oncology case.
*At-risk dogs include all dogs ≥ 7 years old and high-risk breeds ≥ 4 years old.
†Urinalysis is performed on the in-house SediVue Dx Urine Sediment Analyzer.
References
- Data on file at IDEXX Laboratories, Inc. Westbrook, Maine USA: Data based on testing performed at IDEXX Reference Laboratories in North America between November 1, 2024, and December 6, 2024. Analysis Report: IDEXX Cancer Dx Validation, 100282 [008_CancerDx-Validation-Report-2.Rmd].
- What are the most common types of cancers in dogs? How many dogs typically get cancer? Veterinary Cancer Society; 2021. Accessed January 17, 2025. www.vetcancersociety.org/pet-owners/faqs
- International survey of pet owners & veterinarians. Human Animal Bond Research Institute. January 16, 2022. Accessed January 17, 2025. www.habri.org/international-hab-survey